Project Grant R01AI181738
Award Date
1/2/25
Completion Date
12/31/29
Dollars Obligated
$509K
Federal Agency
National Institute of Allergy and Infectious Diseases
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
Tampa, FL 33612, USA
Similar Awards
This $165,000 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports the development of an improved transposon mutagenesis system for comprehensive genetic analysis of Borrelia burgdorferi, the bacterium that causes Lyme disease. The project aims to create a high-efficiency transposon insertional mutagenesis system and employ transposon sequencing techniques to conduct...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $191,250 to Washington State University (WSU) to conduct research on the immune evasion mechanism of the Lyme disease spirochete, Borrelia burgdorferi. The award supports mechanistic studies on the role of genetic factors in the antigenic variation of the VlsE surface protein, a key mechanism for persistent...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) provides $192,500.00 to the University of South Alabama to conduct research on the mechanisms of central nervous system invasion by the Lyme disease spirochete, Borrelia burgdorferi. The key objectives are to: (1) Determine the role of the blood-cerebrospinal fluid barrier as a site for B. burgdorferi and immune cell entry into the central nervous...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $457,875.00 to the University of Connecticut Health Center to conduct research on the role of the alternative sigma factor RpoS in the persistence of Borrelia burgdorferi, the causative agent of Lyme disease, in mammalian hosts. The overarching objective is to elucidate how RpoS-dependent gene regulation...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $461,375 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to Yale University. The grant, effective July 1, 2025 through June 30, 2027, will fund a project to systematically identify interactions between Lyme disease bacteria (Borrelia burgdorferi) and the extracellular, secreted, and transmembrane proteins of its tick vector, Ixodes scapularis. The project aims to develop a...
The Virginia Commonwealth University was awarded a $746,009 Project Grant from the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases. The grant falls under the Allergy and Infectious Diseases Research program (CFDA 93.855) to support research examining the cyclic-di-GMP signaling pathway and its role in the enzootic cycle of Lyme disease from November 18, 2022 through October 31, 2027. Specifically, the grant will fund...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $162,000.00 to The Johns Hopkins University to conduct research on how the host protein epidermal growth factor (EGF) serves as an environmental cue that regulates gene expression in the Lyme disease bacterium Borrelia burgdorferi. The research aims to characterize the binding of EGF to B. burgdorferi and investigate...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $1,663,244 project grant under CFDA 93.855, Allergy and Infectious Diseases Research, to President and Fellows of Harvard College (Harvard Medical School) on March 1, 2025. The project aims to characterize innate immune signaling pathways in the tick Ixodes scapularis, which is a vector for Lyme disease and other emerging infectious diseases. The research will combine cell culture-based methods with in vivo assays in...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $518,099 to the University of Maryland, College Park to investigate a cross-species signaling system in tick immunity and development. The research aims to define how interactions between a novel tick protein (ISCDL) and the tick cell surface receptor DOME1 impact tick immune responses and development, either...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $429,000.00 to The Medical College of Wisconsin, Inc. to conduct research on the effect of the Borrelia burgdorferi-SIRPalpha interaction on the immune response. The goal is to investigate how the pathogen's ability to evade phagocytic clearance through molecular mimicry of "don't eat me" signals subverts the...